201, Avenue Président-Kennedy, Suite 3900
Caprion's Mission is centered on collaborating and partnering with pharmaceutical and biotech companies through proteomics and immune monitoring enabling the acceleration of precision medicine in drug development.
With a vision and deep understanding of the needs for complex immune monitoring in novel drug development, Caprion integrated ImmuneCarta (formerly known as National Immune Monitoring), with its established and proven proteomics service, ProteoCarta. Together, Caprion now offers a fully integrated and unique service offering to its partners.
CEO: Martin LeBlanc
CSO: Daniel Chelsky, Ph.D.
CFO: Normand Rivard, M.Sc.
Chief Business Officer: Carol Berry, MBA